Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Precision financing

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature Biotechnology 41, 597-603 (2023)


Updates & Corrections

  • Update 27 April 2023: A statement in the main text that TargaGenix has shut down has been deleted as it is inaccurate. In addition, two rows were added to Table 1, the first for Orna Therapeutics in 2022 and the second for Chroma Medicine in 2023.

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links